Successful therapy starts with the right device

Philips, following consultation with the Therapeutic Goods Administration (TGA), announced it is conducting an Urgent Product Defect Correction for specific devices in the sleep and respiratory care portfolio. For more information please

click here or call 1800 009 579.

References

2015 User Preference Questionnaire, data on file.
Mask does not directly contact the bridge of the nose or nostrils.
In a retrospective review conducted by Philips Respironics of approximately 15,000 System One patients, patients who used SleepMapper, which has been rebranded DreamMapper, demonstrated 22% greater adherence to the therapy than patients who did not use SleepMapper. To see which therapy devices are compatible with DreamMapper, visit www.dreammapper.com/compatible .

ALWAYS FOLLOW THE DIRECTIONS FOR USE.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue